Tag
Tumore
2022
-
Albumin carrier therapy with methotrexate (MTX-HSA)
A well-tolerated therapy component for advanced tumour diseases with antiproliferative, anti-inflammatory and immunomodulatory effects.
-
Albumin carrier therapy | Case studies
Albumin is the most common protein in the human organism. It has a half-life of 19 days and is responsible for many transport functions in the body.
-
Albumin carrier therapy | Against cancer
Albumin carrier therapy is a low-side-effect treatment for tumours, metastases and inflammation: the active substance is coupled to albumin and carried directly into the tumour cells.